ESC 365 - Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

ESC Premium Access

Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

Session: Valvular heart disease and infective endocarditis e-posters

Topic: Aortic Valve Stenosis

Speaker: Ms M. Kopytek (Krakow, PL)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)

0 follower

130 more presentations in this session

Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis

Speaker: Doctor N. Ngiam (Singapore, SG)

Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.

Speaker: Doctor Z. Cheng (Chengdu, CN)

Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience

Speaker: Doctor S. Mahmood (Detroit, US)

Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis

Speaker: Doctor T. Sugimoto (Tsu, JP)

Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI

Speaker: Doctor V. Jimenez Franco (Madrid, ES)

Access the full session

Valvular heart disease and infective endocarditis e-posters

Speakers: Ms M. Kopytek, Doctor N. Ngiam, Doctor Z. Cheng, Doctor S. Mahmood, Doctor T. Sugimoto...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

27 August 2021

ESC Premium Access

2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study

27 August 2021

ESC Premium Access

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

27 August 2021

ESC 365 is supported by